iRhythm Technologies logo

iRhythm TechnologiesNASDAQ: IRTC

Profile

Sector:

Healthcare

Country:

United States

IPO:

20 October 2016

Next earnings report:

21 February 2025

Last dividends:

N/A

Next dividends:

N/A
$2.66 B
-46%vs. 3y high
84%vs. sector
-vs. 3y high
-vs. sector
-6%vs. 3y high
99%vs. sector
-67%vs. 3y high
59%vs. sector

Price

after hours | 82 min ago
$85.00+$9.96(+13.27%)

Dividend

No data over the past 3 years
$147.54 M$157.33 M
$147.54 M-$46.18 M

Analysts recommendations

Institutional Ownership

IRTC Latest News

iRhythm Technologies, Inc. (IRTC) Q3 2024 Earnings Call Transcript
seekingalpha.com30 October 2024 Sentiment: NEUTRAL

iRhythm Technologies, Inc. (NASDAQ:IRTC ) Q3 2024 Results Conference Call October 30, 2024 4:30 PM ET Company Participants Stephanie Zhadkevich - Director, Investor Relations Quentin Blackford - President and CEO Daniel Wilson - Chief Financial Officer Conference Call Participants Allen Gong - JPMorgan Macauley Kilbane - William Blair Kallum Titchmarsh - Morgan Stanley Marie Thibault - BTIG LLC David Ryman - Goldman Sachs David Rescott - Baird Richard Newitter - Truist William Plovanic - Canaccord Genuity Suraj Kalia - Oppenheimer Operator Hello, everyone, and welcome to iRhythm's Third Quarter 2024 Earnings Call. My name's Lydia, and I'll be your operator today.

IRhythm Technologies (IRTC) Reports Q3 Loss, Tops Revenue Estimates
zacks.com30 October 2024 Sentiment: NEUTRAL

IRhythm Technologies (IRTC) came out with a quarterly loss of $1.26 per share versus the Zacks Consensus Estimate of a loss of $0.55. This compares to loss of $0.89 per share a year ago.

iRhythm Technologies Receives FDA 510(k) Clearance for Design Modifications to Its Zio® AT Device
globenewswire.com30 October 2024 Sentiment: POSITIVE

Zio AT device, along with the Zio ECG Utilization Software (ZEUS) (K222389), enables the provision of ambulatory Mobile Cardiac Telemetry (MCT) monitoring service for non-critical care patients

Newly Published Research Shows 14-Day Monitoring Detected Almost Three Times More Nonsustained Ventricular Tachycardia Than Standard 48-Hour Monitoring in Patients with Hypertrophic Cardiomyopathy
globenewswire.com28 October 2024 Sentiment: POSITIVE

SAN FRANCISCO, Oct. 28, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health company focused on creating trusted solutions that detect, predict, and prevent disease, today announced that the results of the Extended Ambulatory ECG Monitoring Enhances Identification of Higher-Risk Ventricular Tachyarrhythmias in Patients with Hypertrophic Cardiomyopathy (EXAMINE-HCM) study have been published in Heart Rhythm Journal . The findings were also presented at the Heart Rhythm Society's annual meeting in 2023, and most recently, at the International HCM Summit 8 in Boston, MA (October 25-28, 2024).

With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says
benzinga.com22 October 2024 Sentiment: POSITIVE

On Monday, the FDA approved iRhythm Technologies, Inc.'s IRTC 510(k) submission related to prior design changes to the Zio AT device via letter to file.

iRhythm Technologies Stock Rises Post FDA Clearance for Zio AT
zacks.com22 October 2024 Sentiment: POSITIVE

IRTC receives FDA 510(k) clearance for prior design modifications to its Zio AT device, reinforcing its commitment to quality and compliance.

Kaskela Law LLC Announces Shareholder Investigation of iRhythm Technologies, Inc. (NASDAQ: IRTC) and Encourages Long-Term IRTC Shareholders to Contact the Firm
globenewswire.com20 September 2024 Sentiment: NEGATIVE

PHILADELPHIA, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Kaskela Law LLC announces that it is investigating iRhythm Technologies, Inc. (NASDAQ: IRTC) (“iRhythm”) on behalf of the company's long-term shareholders.

iRhythm's Zio ECG System Gets Approval in Japan, Stock Falls
zacks.com13 September 2024 Sentiment: POSITIVE

IRTC's Zio ECG monitoring system gets approval in Japan, marking a significant step in revolutionizing arrhythmia diagnostics with AI-powered technology.

iRhythm Technologies Announces Japanese Regulatory Approval of the Zio® ECG Monitoring System, the First Product to Deliver Arrhythmia Monitoring Service Utilizing Artificial Intelligence
globenewswire.com11 September 2024 Sentiment: POSITIVE

SAN FRANCISCO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that it has received regulatory approval from the Japanese Pharmaceutical and Medical Device Agency (PMDA) for the Zio® fourteen-day, long-term continuous ECG monitoring system. With regulatory approval in hand, iRhythm intends to work towards a reimbursement decision for the Zio ECG monitoring system with the Japanese Ministry of Health, Labour, and Welfare (MHLW).

iRhythm Stock Gains Following Favorable Zio Monitor Study Data
zacks.com10 September 2024 Sentiment: POSITIVE

IRTC announces initial findings demonstrating the superior real-world performance of the next-generation Zio LTCM Monitor at the HRX 2024 meeting.

  • 1(current)
  • 2

What type of business is iRhythm Technologies?

iRhythm Technologies, Inc. is a digital company serving the healthcare industry. It is a provider of ECG ambulatory monitoring solutions for patients at risk of arrhythmias - portable Zio service biosensors with cloud data analysis. It is a vertically integrated company headquartered in San Francisco, California. The company was founded on September 14, 2006. The company's flagship product is the Zio service platform, which provides a wide range of capabilities for ambulatory heart monitoring. The platform combines a convenient and unobtrusive biosensor for wearing (up to 14 consecutive days) with powerful patented algorithms that turn data from a million heartbeats into clinically actionable information.

What sector is iRhythm Technologies in?

iRhythm Technologies is in the Healthcare sector

What industry is iRhythm Technologies in?

iRhythm Technologies is in the Medical Devices industry

What country is iRhythm Technologies from?

iRhythm Technologies is headquartered in United States

When did iRhythm Technologies go public?

iRhythm Technologies initial public offering (IPO) was on 20 October 2016

What is iRhythm Technologies website?

https://www.irhythmtech.com

Is iRhythm Technologies in the S&P 500?

No, iRhythm Technologies is not included in the S&P 500 index

Is iRhythm Technologies in the NASDAQ 100?

No, iRhythm Technologies is not included in the NASDAQ 100 index

Is iRhythm Technologies in the Dow Jones?

No, iRhythm Technologies is not included in the Dow Jones index

When was iRhythm Technologies the previous earnings report?

No data

When does iRhythm Technologies earnings report?

The next expected earnings date for iRhythm Technologies is 21 February 2025